SEC Form 3 · accession 0001627260-15-000001
Skye Bioscience, Inc. · SKYE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard D. Squires
10% Owner
Period of report
Apr 3, 2015
Accepted (ET)
Apr 16, 2015 · 4:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,485,000 | D | ||
| Common StockF1,F3 | holding | — | — | — | 15,000 | I | See Footnote #1 and #3 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) | $1.00 | holding | — | — | — | Jun 4, 2015 | Jun 4, 2019 | Common Stock | 371,250 | — | D |
| Common Stock Warrant (right to buy)F2,F3 | $1.00 | holding | — | — | — | Jun 4, 2015 | Jun 4, 2019 | Common Stock | 3,750 | — | I |
Explanation of responses
- F1Represents shares of Common Stock directly owned by RS Holdings, Inc.
- F2Represents shares of Common Stock Warrants directly owned by RS Holdings, Inc.
- F3Mr. Squires disclaims beneficial ownership of any securities directly owned by RS Holdings, Inc. reported herein except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all such shares for purposes of Section 16 or for any other purpose.